Medical/Pharmaceuticals

Ally Bridge Group Leads US$150 million Financing for Three U.S. Companies Amidst the COVID-19 Pandemic

NEW YORK and HONG KONG, May 21, 2020 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it led three investments in the U.S. -- two medtech and one telehealth -- in April, 2020 amidst the COVID-19 pandemic. Each of the three companies is ...

2020-05-21 20:00 9876

Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

STOCKHOLM, May 21, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated...

2020-05-21 16:18 2261

Dr Ivan Puah, Medical Director Of Amaris B. Clinic, Observes Positive Correlation Between Stress, Weight Gain And Physical Body Pain

SINGAPORE, May 21, 2020 /PRNewswire/ -- The COVID-19 pandemic has disrupted the lives and livelihood of many people. It has caused insecurities, anxiety and a feeling of helplessness among those affected. All these and more increase stress levels and if not managed well can lead to a multitude...

2020-05-21 14:12 3965

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

SEATTLE, May 21, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership withTakara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, wit...

2020-05-21 14:00 3654

Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purcha...

2020-05-21 12:00 14375

Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT'

SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18th. ...

2020-05-21 10:03 4156

Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities

MISBACH, Germany, May 20, 2020 /PRNewswire/ -- Luye Pharma Group announced today that the Marketing Authorization Application (MAA) within the European territory for its Rivastigmine Multi-Day Transdermal Patch (Brand Name: Rivalif® , Product Code: LY30410), an innovative drug delivery system, is ...

2020-05-20 19:34 3416

Retailers Rely on DERMALOG's Fever Screening

The Corona pandemic poses significant challenges for retail stores and shopping centers. Businesses must implement numerous health protection measures without compromising customer experience too much. This is why German Scandinavian Park mall has opted for DERMALOG's non-contact fever detection....

2020-05-20 19:27 2361

INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

-  Publication in Nature Communications demonstrates generation of robust neutralizing antibodies and T cell responses against SARS-CoV-2 -  Preliminary safety and immune responses data from Phase 1 clinical trial expected in June -  Multiple animal challenge study data expected in coming weeks ...

2020-05-20 19:00 2978

COUCH Health Demands the Clinical Research Industry Improves Participant Diversity

As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversi...

2020-05-20 16:00 1299

It's time to talk: Relationships Australia NSW launches free telephone hotline

SYDNEY, May 20, 2020 /PRNewswire/ -- Relationships Australia NSW has launched Time 2 Talk, a brand-new telephone hotline that provides support and advice to help Australians navigate the complexities of day-to-day living amid COVID-19. Time 2...

2020-05-20 14:28 2913

DKSH partners with International SOS to safeguard staff and supply chain operations during COVID-19

BANGKOK, May 20, 2020 /PRNewswire/ -- DKSH, Asia's leading Market Expansion Services provider for companies seeking to grow their business inAsia and beyond, has entered into a partnership with International SOS, to run DKSH's Total Quarantine Solution in several markets acrossAsia.

2020-05-20 12:00 2699

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy...

2020-05-20 10:40 7387

Glemser Technologies and Arria NLG announce strategic partnership

Together they will accelerate pharma clients' ability to bring life-saving drugs to market through automation of medical and regulatory report writing NEW YORK, May 20, 2020 /PRNewswire/ -- Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaborat...

2020-05-20 01:45 3391

Covis Pharma B.V. Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19

U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco in the Treatment of Non-hospitalized COVID-19 Patients Aged 12 and Above LUXEMBOURG and ZUG, Swi...

2020-05-19 20:00 1666

TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia

Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, May 19, 2020 /PRNewswire/ -- In a paper published online in theJournal of Alzheimer's Disease ( https...

2020-05-19 19:00 2311

QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

NEWARK, Delaware, May 19, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and up...

2020-05-19 18:55 3048

Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat® CDxFLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay became the first FDA approvedFLT3 test and launched as a testing service at LabPMM, Invi...

2020-05-19 18:00 2930

Half-year Figures: ZEISS Looks Back on Good First Six Months Overall

Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) – EBIT at455 million euros (+12 million euros compared to prior year) - The Semiconductor Manufacturing Technology and Medical Technology segments contributed in particular to growth in the first six months - Initial impact...

2020-05-19 17:00 2114

Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy

VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform - VIST®...

2020-05-19 16:20 2064
1 ... 364365366367368369370 ... 396